CharlestonPharma, LLC

CharlestonPharma is a biopharma company, developing monoclonal antibodies against cell surface receptor, nucleolin as therapeutics and diagnostics for cancer.

In 2011, CharlestonPharma has the exclusive worldwide license for the method of production of the fully human monoclonal antibodies (mAbs) from the Medical University of South Carolina and an exclusive worldwide license for the use of the anti-nucleolin antibodies to treat cancer patients and the use of cell surface nucleolin to guide the diagnosis and treatment of cancer patients, the latter two from the University of Louisville.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.charlestonPharma, LLC
Founded2012
Disease Focus
Development Stage
STOCK CODENon Listed
Address
645 Meeting Street, Suite 4,SC 029403
Charleston
United States
Email
Contact Number
+1 843 789 5907

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/charlestonpharma-llc” connections=”true” suffix=””]

Key investor incudes Sears Capital Management.